Exagen (XGN) Other financing activities (2019 - 2026)

Exagen (XGN) has 8 years of Other financing activities data on file, last reported at $295000.0 in Q1 2026.

• Quarterly Other financing activities rose 48.99% year-over-year to $295000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.7 million (up 6834.81% YoY) and the FY2025 annual result came in at $18.6 million, up 10483.52% from the prior year.
• Other financing activities eased to $295000.0 in Q1 2026, from $18.4 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $18.4 million in Q3 2025 to a low of -$125000.0 in Q2 2023.
• A 5-year average of $1.8 million and a median of $154000.0 in 2022 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2022 — Other financing activities sank 50.48% — and 2025, when it surged 22573.17%.
• Tracing XGN's Other financing activities over 5 years: stood at $154000.0 in 2022, then sank by 181.17% to -$125000.0 in 2023, then soared by 223.2% to $154000.0 in 2024, then surged by 11866.23% to $18.4 million in 2025, then slumped by 98.4% to $295000.0 in 2026.
• The last three Other financing activities figures came in at $295000.0 (Q1 2026), $18.4 million (Q3 2025), and $1000.0 (Q2 2025), per Business Quant data.